The synthetic retinoid Am80 delays recovery in a model of multiple sclerosis by modulating myeloid-derived suppressor cell fate and viability
Relapsing–remitting multiple sclerosis (RR-MS) is an inflammatory and demyelinating disease of the central nervous system (CNS). It is characterized by relapsing phases with ongoing neurological affectation that are followed by a remitting period in which inflammatory events are controlled and the p...
Main Authors: | Verónica Moliné-Velázquez, María Cristina Ortega, Virginia Vila del Sol, Carolina Melero-Jerez, Fernando de Castro, Diego Clemente |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2014-07-01
|
Series: | Neurobiology of Disease |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0969996114000783 |
Similar Items
-
The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis
by: Carolina Melero-Jerez, et al.
Published: (2020-07-01) -
The presence and suppressive activity of myeloid-derived suppressor cells are potentiated after interferon-β treatment in a murine model of multiple sclerosis
by: Carolina Melero-Jerez, et al.
Published: (2019-07-01) -
CD200 -dependent and -independent immune-modulatory functions of neural stem cells
by: Tal Arad, et al.
Published: (2021-10-01) -
Peripheral myeloid-derived suppressor cells are good biomarkers of the efficacy of fingolimod in multiple sclerosis
by: Celia Camacho-Toledano, et al.
Published: (2022-11-01) -
Comprehensive Analysis of the Immune and Stromal Compartments of the CNS in EAE Mice Reveal Pathways by Which Chloroquine Suppresses Neuroinflammation
by: Rodolfo Thome, et al.
Published: (2020-06-01)